Pregnancy SmartShop formulas

Comparison · Pregnancy Smart

PTU vs Methimazole During Pregnancy

Assigned clinical reviewerMatt Stahl· PharmDDraft · pending clinical reviewUpdated

How do the options compare?

Options are stacked on five dimensions relevant to pregnancy use: mainstream OB guidance, pregnancy-specific evidence, dosing predictability, onset, and side-effect and interaction profile.

OptionStudied pregnancy doseGuideline supportNotes
Propylthiouracil (PTU)Adjust PTU to maternal thyroid tests using the minimum effective prescribed amountOften preferred when an antithyroid drug is needed during the first trimesterPTU has a less recognizable anomaly pattern than methimazole but is not risk-free. Rare, unpredictable severe liver injury is the major maternal concern.
MethimazoleAdjust methimazole to maternal thyroid tests using the minimum effective prescribed amountAn option after the first trimester; the 2026 guideline does not identify a preferred drug after 16 weeksFirst-trimester exposure has been linked to a distinctive uncommon anomaly pattern. Methimazole generally carries less severe liver concern than PTU.
Switch from PTU to methimazoleNo self-directed conversion ratio or universal weekIndividualized discussion; no preferred continuation or switching strategy after 16 weeks in the 2026 guidelineComparative observational evidence has not shown that switching clearly lowers birth-defect risk versus PTU alone. Dose conversion and thyroid monitoring require an endocrinology plan.
  • MotherToBaby reports a suggested methimazole-associated pattern that includes aplasia cutis, choanal atresia, and esophageal atresia, while also noting conflicting studies and confounding by hyperthyroidism. 1
  • MotherToBaby says PTU may be preferred in the first trimester, but human birth-defect studies are mixed and PTU can cause serious maternal liver injury. 2
  • The FDA PTU label carries a warning for severe liver injury and acute liver failure, identifies PTU as a possible first-trimester choice, and says an alternative antithyroid drug may be advisable afterward. 3
  • A 2023 meta-analysis of 13 studies found higher congenital-anomaly odds with methimazole than PTU, while switching did not significantly lower birth-defect odds compared with PTU alone and liver estimates were imprecise. 4
  • The 2026 American Thyroid Association guideline prefers PTU in the first trimester when medication is needed. After 16 weeks, available evidence does not establish whether continuing PTU or switching to methimazole is preferable; either drug and a switch can carry risks. Continued medication requires thyroid testing generally every 2 to 4 weeks. 5

Which option makes sense?

Options in this comparison can differ substantially in suitability. Please consult your healthcare provider to interpret the evidence, limitations, and cautions before choosing an option or changing your plan.

Disclosure: Pregnancy Smart is a supplement maker. The options compared above sit outside our own product line; this page describes their pregnancy evidence on its own merits.

Frequently asked questions

Why do clinicians use PTU instead of methimazole early in pregnancy?

PTU is often preferred in the first trimester because methimazole has been associated with a recognizable pattern of uncommon birth differences during early organ formation. PTU has its own fetal uncertainty and maternal liver risk, so the choice still depends on disease severity and prior response.

Why might a prescriber switch from PTU to methimazole later?

FDA labeling highlights the potential benefit of limiting ongoing PTU liver exposure. The 2026 American Thyroid Association guideline also considers the risk of unstable thyroid control during a switch and does not identify a preferred drug after 16 weeks. The decision therefore requires an individualized specialist plan.

Which drug has a higher risk of birth defects, PTU or methimazole?

Observational studies generally find a stronger and more recognizable first-trimester anomaly signal with methimazole than with PTU. PTU studies are also mixed and do not establish zero risk. Underlying hyperthyroidism and dual exposure complicate comparisons, so estimates should not be read as causal certainty.

Which drug has a higher risk of liver damage, PTU or methimazole?

PTU carries the greater concern for rare severe liver injury and acute liver failure. FDA labeling warns that onset can be rapid and unpredictable. Methimazole can also affect the liver, but the reason clinicians reconsider PTU after the first trimester is its more serious liver-risk profile.

What week of pregnancy should PTU be switched to methimazole?

There is no automatic switch week. The 2026 American Thyroid Association guideline states that after 16 weeks, evidence does not establish whether continuing PTU or switching to methimazole is preferable. The specialist sets the choice, timing, and laboratory follow-up with the patient.

Can I stop PTU or methimazole when I find out I am pregnant?

Do not stop PTU or methimazole on your own after a positive pregnancy test. Uncontrolled hyperthyroidism is associated with miscarriage, heart failure, thyroid storm, preterm birth, growth problems, and stillbirth. Contact the endocrinology and obstetric teams promptly for thyroid tests and a medication-specific plan.

What symptoms while taking PTU need urgent contact?

While taking PTU, urgently contact the prescriber for loss of appetite, itching, right-upper-abdominal pain, dark urine, yellow skin or eyes, unusual fatigue, fever, or sore throat. FDA labeling links liver symptoms to urgent testing and identifies fever or sore throat as possible agranulocytosis signs.

Do PTU and methimazole affect the baby's thyroid?

Both PTU and methimazole cross the placenta and can suppress fetal thyroid function if exposure is excessive. Graves antibodies can also stimulate the fetal thyroid independently of medication. Maternal thyroid tests, fetal assessment when indicated, and newborn thyroid follow-up are therefore part of care.

References

  1. Methimazole

    MotherToBaby · https://mothertobaby.org/fact-sheets/methimazole/

  2. Propylthiouracil (PTU)

    MotherToBaby · https://mothertobaby.org/fact-sheets/propylthiouracil-ptu/

  3. Propylthiouracil Tablets, USP

    FDA · https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/006188s026lbl.pdf

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.